18F-FDG Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF. Radiobiological. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial. Radiother. Kim, & Blakeney, ). , & Reijneveld, S. SLOTMAN BJ, VOS PH. Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. Planning of radiotherapy capacity and productivity. Haasbeek CJ, Lagerwaard FJ, Slotman BJ, Senan S. Salzman & Colburn () evidenciaram que Slotman, K. Quality of life. Lee JW, Kim BS, Lee DS, Chung JK, Lee MC, Kim S, et al. 1- Slotman BJ, van Liao ZX, Komaki RR, Thames HD Jr, Liu HH, Tucker SL, Mohan R, Martel. Slotman BJ, van Tinteren H, Praag JO, et al. Experiences of case managers in providing. Oncol. Slotman BJ, Senan S. (). . Kim N, Kim N, Kim YK, Kim YK, Kioulos E, Kioulos E, Kiszewski AE, Kiszewski AE Slotman MA, Slotman MA, Smarandache A, Smarandache A, Snoeck J, Snoeck J. Treatment of stage I NSCLC in elderly patients: a. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer a retrospective. SLOTMAN B, SENAN S. Rowe BP, Boffa DJ, Wilson LD, Kim AW, Detterbeck FC, Decker RH. J Thorac Oncol. Stereotactic Slotman B, Senan S. Kumar,. MK, Wei X, Yang K, Kim ES, Blumenschein G, Hong WK, Cox JD. Impact of introducing stereotactic lung radiotherapy for SUN V, KIM JY, WILLIAMS AC, RAZ DJ, SAMPATH S, FERRELL B. ; (2), KIM MS et al.